2010•PubMedOpen access

Proarrhythmia Induced by Propafenone: What is the Mechanism?

Francisco Femenía, Jorge Palazzolo, Mauricio Arce, Martín Arrieta

Open full text 7 citations

Abstract

Propafenone, a Class IC antiarrhythmic drug, is an orally active sodium channel-blocking agent. It is effective in supraventricular tachyarrhythmias and is particularly useful in converting atrial fibrillation to sinus rhythm. In therapeutic doses, it may cause non-cardiac and cardiac toxicity, including proarrhythmia.

About this research paper

What this paper is about

Propafenone, a Class IC antiarrhythmic drug, is an orally active sodium channel-blocking agent. It is effective in supraventricular tachyarrhythmias and is particularly useful in converting atrial fibrillation to sinus rhythm. In therapeutic doses, it may cause non-cardiac and cardiac toxicity, including proarrhythmia.

Why it matters

OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Propafenone, a Class IC antiarrhythmic drug, is an orally active sodium channel-blocking agent. It is effective in supraventricular tachyarrhythmias and is particularly useful in converting atrial fibrillation to sinus rhythm. In therapeutic doses, it may cause non-cardiac and cardiac toxicity, including proarrhythmia.

Key concepts: Proarrhythmia, Propafenone, Medicine, Supraventricular arrhythmia, Sinus rhythm, Torsades de pointes, Cardiology, Atrial fibrillation

Back to paper searchBrowse research topicsOriginal source
Proarrhythmia Induced by Propafenone: What is the Mechanism? — Research Paper | ScholarLens